{"id":"https://openalex.org/W2051264860","doi":"https://doi.org/10.1158/1538-7445.fbcr13-c15","title":"Abstract C15: Therapeutic benefit of targeting ERK in mutant KRAS in pancreatic ductal adenocarcinoma (PDAC)","display_name":"Abstract C15: Therapeutic benefit of targeting ERK in mutant KRAS in pancreatic ductal adenocarcinoma (PDAC)","publication_year":2013,"publication_date":"2013-10-01","ids":{"openalex":"https://openalex.org/W2051264860","doi":"https://doi.org/10.1158/1538-7445.fbcr13-c15","mag":"2051264860"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.fbcr13-c15","doi":"https://doi.org/10.1158/1538-7445.fbcr13-c15","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.fbcr13-c15","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052928890","display_name":"Tikvah K. Hayes","orcid":"https://orcid.org/0000-0003-0008-5246","observed_orcids":["https://orcid.org/0000-0003-0008-5246"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tikvah K. Hayes","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108689874","display_name":"Nicole F. Neel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole F. Neel","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082511041","display_name":"M\u00e9lissa Ch\u00e9nard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa Chenard","raw_affiliation_strings":["2MERCK, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MERCK, Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065098287","display_name":"Jen Jen Yeh","orcid":"https://orcid.org/0000-0003-2542-6211","observed_orcids":["https://orcid.org/0000-0003-2542-6211"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jen Jen Yeh","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033762700","display_name":"Ahmed A. Samatar","orcid":"https://orcid.org/0009-0001-9256-991X","observed_orcids":["https://orcid.org/0009-0001-9256-991X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahmed Samatar","raw_affiliation_strings":["2MERCK, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MERCK, Boston, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064063895","display_name":"Channing J. Der","orcid":"https://orcid.org/0000-0002-7751-2747","observed_orcids":["https://orcid.org/0000-0002-7751-2747"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Channing J. Der","raw_affiliation_strings":["1University of North Carolina at Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina at Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"19_Supplement","first_page":"C15","last_page":"C15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.4691999852657318,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.4691999852657318,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.4406999945640564,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.047600001096725464,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erk1-2-inhibition","display_name":"ERK1/2 inhibition","score":0.781000018119812},{"id":"https://openalex.org/keywords/sch772984","display_name":"SCH772984","score":0.878000020980835},{"id":"https://openalex.org/keywords/mutant-kras","display_name":"mutant KRAS","score":0.8399999737739563},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":1.0},{"id":"https://openalex.org/keywords/mek-inhibitor-resistance","display_name":"MEK inhibitor resistance","score":0.7720000147819519},{"id":"https://openalex.org/keywords/selumetinib","display_name":"selumetinib","score":0.9729999899864197},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.6600000262260437},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/senescence","display_name":"senescence","score":0.8880000114440918},{"id":"https://openalex.org/keywords/p16","display_name":"p16","score":0.8769999742507935},{"id":"https://openalex.org/keywords/rb-phosphorylation","display_name":"retinoblastoma protein phosphorylation","score":0.6650000214576721},{"id":"https://openalex.org/keywords/xenograft-tumor-growth","display_name":"xenograft tumor growth","score":0.7229999899864197},{"id":"https://openalex.org/keywords/kinome-reprogramming","display_name":"kinome reprogramming","score":0.550000011920929}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7963445782661438},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7081359028816223},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6200942397117615},{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.5527759790420532},{"id":"https://openalex.org/C522857546","wikidata":"https://www.wikidata.org/wiki/Q2070979","display_name":"Senescence","level":2,"score":0.5325751900672913},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5094612240791321},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5019760131835938},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.48673108220100403},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.47892412543296814},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.47856026887893677},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.43569400906562805},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4242638349533081},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41648373007774353},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.41336339712142944},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32677584886550903},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2798023819923401},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19952908158302307},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11015844345092773},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.fbcr13-c15","doi":"https://doi.org/10.1158/1538-7445.fbcr13-c15","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.fbcr13-c15","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2050307609","https://openalex.org/W2487521590","https://openalex.org/W4367603582","https://openalex.org/W2562074085","https://openalex.org/W4367602905","https://openalex.org/W2211890826","https://openalex.org/W3083345156","https://openalex.org/W4213054447","https://openalex.org/W4387810552","https://openalex.org/W7214277549"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"limited":[2],"success":[3],"of":[4,32,42,70,73,98,100,125,127,176,188,196,232,235,242,271,289,313,327],"anti-MEK":[5],"and":[6,194,223],"anti-RAF":[7],"therapies":[8],"with":[9,230,252],"KRAS":[10,75,290,318],"mutant":[11,74,291,317],"cancers":[12],"has":[13],"been":[14],"attributed,":[15],"in":[16,205,257,259,316,319,335],"part,":[17],"to":[18,38,82,106,117],"de":[19],"novo":[20],"or":[21],"acquired":[22],"resistance":[23,33,60],"mechanisms":[24,34,124,270],"that":[25,48,94,183,218,250,279],"arise":[26],"after":[27],"prolonged":[28,199],"treatment.":[29],"A":[30],"majority":[31],"involve":[35],"kinome":[36],"reprograming":[37],"reactivate":[39],"ERK":[40,51,281,315],"downstream":[41],"inhibitor":[43,272],"activity.":[44],"Therefore,":[45],"we":[46,66,92,132,144,168,216,248],"hypothesized":[47],"directly":[49],"targeting":[50,280,314],"would":[52],"be":[53,283],"an":[54,258],"effective":[55],"method":[56],"for":[57,139,149,212,286],"overcoming":[58],"these":[59,128,180],"mechanisms.":[61],"To":[62],"address":[63],"this":[64],"possibility,":[65],"evaluated":[67],"the":[68,83,95,118,146,240,269,287,328],"sensitivity":[69,184],"a":[71,136,186],"panel":[72],"pancreatic":[76,320],"ductal":[77,321],"adenocarcinoma":[78,322],"(PDAC)":[79],"cell":[80,102,162,191],"lines":[81,103,114,209],"highly":[84],"selective":[85],"SCH772984":[86,107,141,200,253],"ERK1/2":[87],"protein":[88,245],"kinase":[89],"inhibitor.":[90],"First,":[91],"found":[93,169,217,249],"anchorage-dependent":[96,150],"growth":[97,151,256],"6":[99],"12":[101],"were":[104,115],"sensitive":[105,112,208],"treatment":[108,201,251,288],"(IC50<2":[109],"\u03bcM).":[110],"Some":[111],"PDAC":[113,140],"resistant":[116],"AZD6244":[119],"MEK1/2-selective":[120],"inhibitor,":[121],"indicating":[122],"different":[123],"action":[126],"two":[129,226],"inhibitors.":[130],"Second,":[131],"identified":[133],"phospho-AKT":[134],"as":[135,172,207],"potential":[137],"biomarker":[138],"sensitivity.":[142],"Third,":[143],"assessed":[145],"molecular":[147],"basis":[148],"inhibition.":[152],"After":[153],"72":[154],"h":[155],"treatment,":[156],"flow":[157],"cytometry":[158],"analyses":[159],"indicated":[160],"impaired":[161,190],"cycle":[163,192],"progression":[164,193],"through":[165],"G1.":[166],"Additionally,":[167],"increased":[170],"apoptosis":[171],"measured":[173],"by":[174],"formation":[175],"cleaved":[177],"caspase-3.":[178],"Together":[179],"observations":[181],"suggest":[182,278],"is":[185],"result":[187],"both":[189],"induction":[195,231],"apoptosis.":[197],"Surprisingly":[198],"(2":[202],"weeks)":[203],"resulted":[204],"senescence,":[206],"stained":[210],"positive":[211],"senescence-associated":[213],"beta-galactocidase.":[214],"Furthermore,":[215],"senescent":[219],"cells":[220],"induced":[221],"p16":[222],"lost":[224],"phospho-RB":[225],"common":[227],"markers":[228],"associated":[229],"senescence.":[233],"Onset":[234],"senescence":[236],"was":[237],"dependent":[238],"on":[239,333],"loss":[241],"total":[243],"MYC":[244],"expression.":[246],"Finally,":[247],"reduced":[254],"tumorigenic":[255],"vivo":[260],"xenograft":[261],"mouse":[262],"model.":[263],"Our":[264],"ongoing":[265],"studies":[266],"include":[267],"determining":[268],"resistance.":[273],"In":[274],"summary,":[275],"our":[276],"findings":[277],"will":[282],"therapeutically":[284],"beneficial":[285],"PDAC.":[292],"Citation":[293],"Format:":[294],"Tikvah":[295],"K.":[296],"Hayes,":[297],"Nicole":[298],"F.":[299],"Neel,":[300],"Melissa":[301],"Chenard,":[302],"Jen":[303,304],"Yeh,":[305],"Ahmed":[306],"Samatar,":[307],"Channing":[308],"J.":[309],"Der.":[310],"Therapeutic":[311],"benefit":[312],"(PDAC).":[323],"[abstract].":[324],"In:":[325],"Proceedings":[326],"Third":[329],"AACR":[330],"International":[331],"Conference":[332],"Frontiers":[334],"Basic":[336],"Cancer":[337,348],"Research;":[338],"Sep":[339],"18-22,":[340],"2013;":[341],"National":[342],"Harbor,":[343],"MD.":[344],"Philadelphia":[345],"(PA):":[346],"AACR;":[347],"Res":[349],"2013;73(19":[350],"Suppl):Abstract":[351],"nr":[352],"C15.":[353]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}